These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13310637)

  • 41. [Study of the properties of Bacterium tularense and its biological correlation to host animals and tick-transmitters].
    OLSUF'EV NG; DUNAEVA TN; EMEL'IANOVA OS; PETROV VG
    Vestn Akad Med Nauk SSSR; 1950; 3():20-9. PubMed ID: 14776875
    [No Abstract]   [Full Text] [Related]  

  • 42. Studies on thermostable antigens extracted from Bacterium tularense and from tissues of animals dead of tularemia.
    LARSON CL
    J Immunol; 1951 Feb; 66(2):249-59. PubMed ID: 14814305
    [No Abstract]   [Full Text] [Related]  

  • 43. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
    Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
    Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tularemia vaccines: recent developments and remaining hurdles.
    Conlan JW
    Future Microbiol; 2011 Apr; 6(4):391-405. PubMed ID: 21526941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison.
    Rohmer L; Brittnacher M; Svensson K; Buckley D; Haugen E; Zhou Y; Chang J; Levy R; Hayden H; Forsman M; Olson M; Johansson A; Kaul R; Miller SI
    Infect Immun; 2006 Dec; 74(12):6895-906. PubMed ID: 17000723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Culture of P. tularensis in the 1966-67 outbreaks of tularemia in Sweden. Laboratory methods and precautions against laboratory infections.
    Ringertz O; Dahlstrand S
    Acta Pathol Microbiol Scand; 1968; 72(3):464. PubMed ID: 5689988
    [No Abstract]   [Full Text] [Related]  

  • 48. [Study of the immunizing effect of the virulent Tularemia strain treated by streptomycin].
    Brikman DI
    Antibiotiki; 1971 Sep; 16(9):827-31. PubMed ID: 5139456
    [No Abstract]   [Full Text] [Related]  

  • 49. Tularemia; report of a case of primary tularemic tonsillitis in which Bacterium tularense was isolated from the sputum.
    JORDAN RA; DOWNS CM
    J Kans Med Soc; 1949 Aug; 50(8):390. PubMed ID: 18136202
    [No Abstract]   [Full Text] [Related]  

  • 50. Studies on pathogenesis and immunity in tularemia; immune response of the white rat to Bacterium tularense.
    BUCHELE L; DOWNS CM
    J Immunol; 1949 Oct; 63(2):135-45. PubMed ID: 15390503
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on the pathogenesis and immunity in tularemia; the course of infection with Bacterium tularense as seen in the normal, vaccinated, and recovered white rat.
    DOWNS CM; BUCHELE L; OWEN BJ
    J Bacteriol; 1947 Jul; 54(1):83. PubMed ID: 20344312
    [No Abstract]   [Full Text] [Related]  

  • 52. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
    Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Possibilities of simultaneous vaccination against tularemia and brucellosis. II. Indices of immunologic transformation in guinea pigs following simultaneous topical vaccination against tularemia and brucellosis].
    PILIPENKO VG; POLIAKOVA AM
    Zh Mikrobiol Epidemiol Immunobiol; 1955 May; 5():9-14. PubMed ID: 14397751
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunizing properties of strains of Pasteurella tularensis with low virulence.
    SKRODZKI E; TOMASZUNAS S
    Biul Panstw Inst Med Morsk Trop J W Gdansku; 1956; 7():86-95. PubMed ID: 13342904
    [No Abstract]   [Full Text] [Related]  

  • 56. Biosafety and selectable markers.
    Titball RW; Sjostedt A; Pavelka MS; Nano FE
    Ann N Y Acad Sci; 2007 Jun; 1105():405-17. PubMed ID: 17416926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tularemia vaccines - an overview.
    McMurry JA; Moise L; Gregory SH; De Groot AS
    Med Health R I; 2007 Oct; 90(10):311-4. PubMed ID: 18019188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of aureomycin upon infections with Bacterium tularense in experimental animals.
    LARSON CL
    J Immunol; 1949 Aug; 62(4):425-36. PubMed ID: 18133626
    [No Abstract]   [Full Text] [Related]  

  • 59. Streptomycin studies in tularemia; the effect of streptothricin and streptomycin on Bacterium tularense in vitro and in vivo (mouse).
    CHAPMAN SS; DOWNS CM
    J Infect Dis; 1949; 85(1):25-38. PubMed ID: 18132368
    [No Abstract]   [Full Text] [Related]  

  • 60. The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.
    Rees DG; Hartley MG; Green M; Lukaszewski RA; Griffin KF; Atkins HS; Lyons R; Krieg AM; Titball RW
    Microb Pathog; 2013 Oct; 63():16-8. PubMed ID: 23707360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.